TELA Bio
TELA
36 hedge funds and large institutions have $135M invested in TELA Bio in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
1.87% more ownership
Funds ownership: 70.76% → 72.63% (+1.9%)
4% less capital invested
Capital invested by funds: $140M → $135M (-$5.03M)
3% less funds holding
Funds holding: 37 → 36 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$915K |
| 2 |
CAC
Cowen and Company
New York
|
+$531K |
| 3 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$253K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$251K |
| 5 |
RI
RTW Investments
New York
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$655K |
| 2 |
WP
WMS Partners
Towson,
Maryland
|
-$373K |
| 3 |
E
Ergoteles
New York
|
-$305K |
| 4 |
Renaissance Technologies
New York
|
-$224K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$208K |
TELA Hedge Fund Activity: Q4 2021 in Review
36 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q4 2021, worth a combined $135M — down 3.6% from $140M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TELA and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 11 added.
The largest buyer was Essex Woodlands Management, adding an estimated $915K. The largest seller was Nomura Holdings, exiting entirely with an estimated $655K sold.
- 36 institutional investors held TELA Bio (TELA) as of Q4 2021, down from 37 in Q3 2021.
- Funds reported $135M of TELA Bio stock for Q4 2021, down 3.6% quarter-over-quarter.
- 3 funds opened new TELA Bio positions in Q4 2021 and 4 closed out, a net change of -1 holder.
- The largest TELA Bio buyer in Q4 2021 was Essex Woodlands Management, an estimated $915K added.
- The largest TELA Bio seller in Q4 2021 was Nomura Holdings, an estimated $655K sold.
Based on aggregated 13F filings for Q4 2021.